Literature DB >> 21453246

Impaired neural transmission and synaptic plasticity in superior cervical ganglia from β-amyloid rat model of Alzheimer's disease.

K H Alzoubi1, I A Alhaider, T T Tran, A Mosely, K K Alkadhi.   

Abstract

Basal synaptic transmission and activity-dependent synaptic plasticity were evaluated in superior cervical sympathetic ganglia (SCG) of amyloid-β rat model of Alzheimer's disease (Aβ rat) using electrophysiological and molecular techniques. Rats were administered Aβ peptides (a mixture of 1:1 Aβ1-40 and Aβ1-42) by chronic intracerebroventricular infusion via 14-day mini-osmotic pumps (300 pmol/day). Control rats received Aβ40-1 (inactive reverse peptide: 300 pmol/day). Ganglionic compound action potentials were recorded before (basal) and after repetitive stimulation. In isolated SCG, ganglionic long-term potentiation (gLTP) was generated by a brief train of stimuli (20Hz for 20s) and ganglionic long-term depression (gLTD) was produced with trains of paired pulses. The input/output (I/O) curves of ganglia from Aβ rats showed a marked downward shift along all stimulus intensities, compared to those of ganglia from control animals, indicating impaired basal synaptic transmission. In addition, repetitive stimulation induced robust gLTP and gLTD in ganglia isolated from control animals, but, the same protocols failed to induce gLTP or gLTD in ganglia from Aβ rats indicating impairment of activity-dependent synaptic plasticity in these animals. Western blotting of SCG homogenate from Aβ rats revealed reduction in the ratio of phosphorylated-/total-CaMKII and in calcineurin protein levels. Although other mechanisms could be involved, these changes in signaling molecules could represent an important molecular mechanism linked to the failure to express synaptic plasticity in Aβ rat ganglia. Results of the current study could explain some of the peripheral nervous system manifestations of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453246     DOI: 10.2174/156720511795745311

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  9 in total

1.  Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology.

Authors:  An T Dao; Munder A Zagaar; Amber T Levine; Samina Salim; Jason L Eriksen; Karim A Alkadhi
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

2.  Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer's Disease.

Authors:  Hari Shanker Sharma; Dafin Fior Muresanu; José Vicente Lafuente; Ranjana Patnaik; Z Ryan Tian; Asya Ozkizilcik; Rudy J Castellani; Herbert Mössler; Aruna Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 3.  Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis.

Authors:  Qiujian Yu; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2017-11-24       Impact factor: 5.203

4.  Diabetes impairs synaptic plasticity in the superior cervical ganglion: possible role for BDNF and oxidative stress.

Authors:  K H Alzoubi; O F Khabour; I A Alhaidar; A M Aleisa; K A Alkadhi
Journal:  J Mol Neurosci       Date:  2013-07-06       Impact factor: 3.444

5.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

6.  Moderate Treadmill Exercise Protects Synaptic Plasticity of the Dentate Gyrus and Related Signaling Cascade in a Rat Model of Alzheimer's Disease.

Authors:  An T Dao; Munder A Zagaar; Karim A Alkadhi
Journal:  Mol Neurobiol       Date:  2014-10-08       Impact factor: 5.590

7.  Regular exercise prevents non-cognitive disturbances in a rat model of Alzheimer's disease.

Authors:  An T Dao; Munder A Zagaar; Samina Salim; Jason L Eriksen; Karim A Alkadhi
Journal:  Int J Neuropsychopharmacol       Date:  2013-11-14       Impact factor: 5.176

8.  Protective role of Dihydromyricetin in Alzheimer's disease rat model associated with activating AMPK/SIRT1 signaling pathway.

Authors:  Ping Sun; Jun-Bo Yin; Li-Hua Liu; Jian Guo; Sheng-Hai Wang; Chun-Hui Qu; Chun-Xia Wang
Journal:  Biosci Rep       Date:  2019-01-03       Impact factor: 3.840

Review 9.  Using multielectrode arrays to investigate neurodegenerative effects of the amyloid-beta peptide.

Authors:  Steven Schulte; Manuela Gries; Anne Christmann; Karl-Herbert Schäfer
Journal:  Bioelectron Med       Date:  2021-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.